NCT03432611

Brief Summary

With a randomized, pragmatic study the effectiveness of a smartphone app for menstrual pain in 18-34-year-old women with primary dysmenorrhea will be investigated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
594

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 14, 2018

Completed
5 days until next milestone

Study Start

First participant enrolled

February 19, 2018

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

July 31, 2019

Status Verified

July 1, 2019

Enrollment Period

2.5 years

First QC Date

January 18, 2018

Last Update Submit

July 30, 2019

Conditions

Keywords

mHealthdysmenorrheaacupressureself-managementself-care

Outcome Measures

Primary Outcomes (1)

  • Mean pain intensity on the days with pain

    The mean pain intensity on the days with pain during the 6th menstruation after randomization using a numerical rating scale (NRS; 0=no pain; 10=strongest pain imaginable).

    Daily during the 6th menstruation after randomization

Secondary Outcomes (9)

  • Mean pain intensity on the days with pain

    Baseline; daily during menstruation (1st to 5th and 7th to 12th menstrual cycles)

  • Responder

    Daily during menstruation (1st to 12th menstrual cycles)

  • Number of days with pain (duration of pain)

    Daily during menstruation (1st to 12th menstrual cycles)

  • Days with absence from work, training, or studies

    Baseline, end of menstruation (1st to 12th menstrual cycles)

  • Days with pain medication

    Daily during menstruation (1st to 12th menstrual cycles)

  • +4 more secondary outcomes

Study Arms (3)

Complete app

EXPERIMENTAL

198 women with primary dysmenorrhea who receive an app which includes a self-care information feature and a self-acupressure feature.

Other: Self-care information featureOther: Self-acupressure feature

Control intervention I

ACTIVE COMPARATOR

198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-care information feature, but not the self-acupressure feature.

Other: Self-care information feature

Control intervention II

ACTIVE COMPARATOR

198 women with primary dysmenorrhea who receive an app for menstrual pain which includes the self-acupressure feature, but not the self-care information feature.

Other: Self-acupressure feature

Interventions

The self-care feature offers information on self-care for menstrual pain. The following topics are shown: exercise, dietary supplementation, heating pad/hot water bottle, yoga, and information on when to consult a doctor and how primary dysmenorrhoea is often treated. Notifications from the app which can be deactivated remind women of surveys and activities.

Complete appControl intervention I

The acupressure feature offers detailed written and multimedia descriptions of an acupressure used for menstrual pain. Three acupressure points are described, which should be massaged bilaterally twice a day up to five times a day on the 5 days before menstruation and during menstruation. Each point should be massaged for 2 minutes. A timer for the acupressure and notifications from the app which can be deactivated remind women of surveys and acupressure.

Complete appControl intervention II

Eligibility Criteria

Age18 Years - 34 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with menstrual pain
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female, aged 18-34 years
  • Dysmenorrhea, defined as self-reported menstrual cramps or pain during every menstrual cycle which started during the teenage years
  • No prior history of a gynecological disease that is known to be a reason for the dysmenorrhea
  • Not more than 5 days with menstrual pain outside the menstrual period itself
  • Menstruation within the last six weeks and a cycle length of 3 to 6 weeks
  • Moderate or severe pain, defined as a score equal to or higher than 6 on a numeric rating scale (NRS, 0 to 10) for the worst pain intensity during the last menstruation
  • Informed consent
  • Possession of an iPhone
  • Willingness and ability to input and share anonymous data through the study app
  • The willingness to see a doctor when 1) pain is getting worse than usual, 2) pain medication is not helping, and 3) when the pain is still present well before or well after the period.

You may not qualify if:

  • Known pregnancy
  • Pregnancy already planned for the forthcoming 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité - Universitätsmedizin Berlin

Berlin, Germany

RECRUITING

Related Publications (1)

  • Wang J, Rogge AA, Armour M, Smith CA, D'Adamo CR, Pischke CR, Yen HR, Wu MY, More AOO, Witt CM, Pach D. International ResearchKit App for Women with Menstrual Pain: Development, Access, and Engagement. JMIR Mhealth Uhealth. 2020 Feb 11;8(2):e14661. doi: 10.2196/14661.

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Claudia M. Witt, MD

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR
  • Daniel Pach, MD

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: randomized, three-armed pragmatic study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med.

Study Record Dates

First Submitted

January 18, 2018

First Posted

February 14, 2018

Study Start

February 19, 2018

Primary Completion

September 1, 2020

Study Completion

March 1, 2021

Last Updated

July 31, 2019

Record last verified: 2019-07

Locations